BB BIOTECH AG

13F Filings History

Latest 13F report
Q4 2024 - Feb 14, 2025
Signature - Title
Martin Gubler / Ivo Betschart - SIGNING AUTHORITY
Location
Schaffhausen, Switzerland
Summary
This page shows a list of all the recent 13F filings made by BB BIOTECH AG. Form 13F is required to be filed within 45 days of the end of a calendar quarter. BB BIOTECH AG reported 35 stock holdings with total value $3.98B as of Q1 2019. Top holdings included IONS, INCY, NBIX, VRTX, and SAGE. Bellevue Group AG is reporting for BB BIOTECH AG.
Holdings Value

Bellevue Group AG is reporting for BB BIOTECH AG:

Name Holdings Value Location File Number
Bellevue Group AG $5.19B Kuesnacht, Switzerland 028-17462
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 13F-NT 2/14/2025, 04:18 PM
Q3 2024 13F-NT 11/14/2024, 05:23 PM
Q2 2024 13F-NT 8/14/2024, 02:11 PM
Q1 2024 13F-NT 5/15/2024, 03:07 PM
Q4 2023 13F-NT 2/14/2024, 12:17 PM
Q3 2023 13F-NT 11/14/2023, 01:59 PM
Q2 2023 13F-NT 8/14/2023, 01:58 PM
Q1 2023 13F-NT 5/15/2023, 10:31 AM
Q4 2022 13F-NT 2/14/2023, 11:51 AM
Q3 2022 13F-NT 11/14/2022, 01:01 PM
Q2 2022 13F-NT 8/11/2022, 11:01 AM
Q1 2022 13F-NT 5/13/2022, 04:24 PM
Q4 2021 13F-NT 2/10/2022, 09:57 AM
Q3 2021 13F-NT 11/12/2021, 05:35 AM
Q2 2021 13F-NT 8/12/2021, 12:54 PM
Q1 2021 13F-NT 5/11/2021, 05:49 PM
Q4 2020 13F-NT 2/16/2021, 08:10 AM
Q3 2020 13F-NT 11/16/2020, 03:25 PM
Q2 2020 13F-NT 8/13/2020, 04:07 PM
Q1 2020 13F-NT 5/14/2020, 02:26 PM
Q4 2019 13F-NT 2/14/2020, 01:33 PM
Q3 2019 13F-NT 11/14/2019, 03:58 PM
Q2 2019 13F-NT 8/14/2019, 02:29 PM
Q1 2019 35 $3.98B +$159M -$134M +$24.9M IONS, INCY, NBIX, VRTX, SAGE 13F-HR 5/13/2019, 12:49 PM
Q4 2018 34 $3.12B +$322M -$132M +$190M IONS, INCY, NBIX, VRTX, ESPR 13F-HR 2/12/2019, 04:21 PM
Q3 2018 32 $3.78B +$164M -$124M +$39.4M IONS, NBIX, CELG, VRTX, INCY 13F-HR 11/9/2018, 03:57 PM
Q2 2018 32 $3.46B +$225M -$85M +$140M IONS, NBIX, CELG, INCY, VRTX 13F-HR 8/9/2018, 04:17 PM
Q1 2018 30 $3.62B +$169M -$46.9M +$122M IONS, INCY, CELG, NBIX, VRTX 13F-HR 5/8/2018, 05:23 PM
Q4 2017 30 $3.55B +$159M -$26.4M +$132M IONS, CELG, INCY, NBIX, VRTX 13F-HR 2/14/2018, 02:39 PM
Q3 2017 27 $3.61B +$159M -$36.2M +$123M CELG, INCY, IONS, GILD, VRTX 13F-HR 11/13/2017, 10:56 AM
Q2 2017 28 $3.27B +$90.4M -$66.2M +$24.2M INCY, CELG, IONS, RDUS, GILD 13F-HR 8/11/2017, 01:46 PM
Q1 2017 30 $3.06B +$92M -$99.9M -$7.88M INCY, CELG, IONS, GILD, RDUS 13F-HR 5/10/2017, 12:34 PM
Q4 2016 29 $2.7B +$80.6M -$17.4M +$63.2M CELG, INCY, IONS, GILD, RDUS 13F-HR 2/14/2017, 01:10 PM
Q3 2016 29 $2.84B +$107M -$46.5M +$60.9M INCY, CELG, IONS, RDUS, GILD 13F-HR 11/10/2016, 03:17 PM
Q2 2016 30 $2.53B +$89.3M -$41.9M +$47.4M CELG, INCY, GILD, IONS, RDUS 13F-HR 8/12/2016, 04:55 PM
Q1 2016 29 $2.52B +$37.8M -$773K +$37M CELG, INCY, IONS, GILD, ALXN 13F-HR 5/12/2016, 05:12 PM
Q4 2015 30 $3.55B +$475M -$24.2M +$451M CELG, INCY, IONS, GILD, RDUS 13F-HR 2/9/2016, 04:02 PM
Q3 2015 28 $3.15B +$323M -$2.18M +$321M INCY, CELG, RDUS, GILD, ISIS 13F-HR 11/12/2015, 07:48 AM
Q2 2015 29 $3.69B +$230M -$42.8M +$187M CELG, INCY, ISIS, GILD, RDUS 13F-HR 8/12/2015, 12:03 PM
Q1 2015 27 $3.36B +$138M -$112M +$25.7M CELG, ISIS, INCY, GILD, AGIO 13F-HR 5/14/2015, 03:12 PM
Q4 2014 28 $3.09B +$176M -$117M +$59.4M CELG, ISIS, INCY, GILD, AGIO 13F-HR 2/12/2015, 04:27 PM
Q3 2014 26 $2.46B +$205M -$163M +$42M CELG, GILD, ISIS, INCY, VRTX 13F-HR 11/13/2014, 03:53 PM
Q2 2014 24 $2.1B +$317M -$6.42M +$310M CELG, GILD, INCY, ISIS, VRTX 13F-HR 8/7/2014, 03:43 PM
Q1 2014 24 $1.94B +$71.2M -$32.9M +$38.3M CELG, ISIS, GILD, INCY, ALXN 13F-HR 5/8/2014, 04:51 PM
Q4 2013 23 $1.87B CELG, GILD, ISIS, INCY, VRTX 13F-HR 2/12/2014, 11:36 AM